Xiaoqing Shi
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Osteoarthritis Treatment and Mechanisms, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Computational Drug Discovery Methods, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase(2004)630 cited
- → Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity(2005)295 cited
- → Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)(2002)263 cited
- → Generation of SO3−and OH radicals in SO32− reactions with inorganic environmental pollutants and its implications to SO32−toxicity(1994)169 cited
- → Stress-induced Inhibition of ERK1 and ERK2 by Direct Interaction with p38 MAP Kinase(2001)166 cited
- → Generation of hydroxyl radical by chromate in biologically relevant systems: role of Cr(V) complexes versus tetraperoxochromate(V).(1994)94 cited
- → B23/Nucleophosmin Serine 4 Phosphorylation Mediates Mitotic Functions of Polo-like Kinase 1(2004)80 cited
- → Effect of intramedullary nail and locking plate in the treatment of proximal humerus fracture: an update systematic review and meta-analysis(2019)65 cited
- → Casticin suppresses monoiodoacetic acid-induced knee osteoarthritis through inhibiting HIF-1α/NLRP3 inflammasome signaling(2020)64 cited
- → Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/AKT and NF-κB pathways(2022)63 cited